gradientForSurfBreak.png

Item List

Buesinesswire
COMPaSS™ Personalized Spine Surgery Study Begins Enrollment

Carlsmed® announced today that the first patients have been enrolled in the COMPaSS™ study. COMPaSS, Clinical Outcome Measures in Personalized aprevo® Spine Surgery, is a multi-center post market prospective observational registry. The study will collect data on patients with degenerative spinal conditions and are treated surgically with Carlsmed aprevo devices and will track outcomes for a period of two years.

Recent Posts

General News

Carlsmed.png

At HLTH 2022, a New Chapter for AI
...

MedCity News

General News

Carlsmed.png

HCA CEO to Big Tech: You Can’t Disrupt Healthcare Like You’ve Disrupted Other In ...

MedCity News

Wavemaker 360 News

Carlsmed.png

Wavemaker Three-Sixty Health Celebrates Investment Milestone at HLTH 2022: 50 Co ...

Yahoo

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png